TransMedics Group annual operating margin
2018
2019
2020
2021
2022
2023
2024
2025
TransMedics Group's operating margin was 17.93% for fiscal 2025.
View full TransMedics Group company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 17.93% | +9.44 pp |
| 2024 | 2024-12-31 | 8.49% | +20.38 pp |
| 2023 | 2023-12-31 | −11.89% | +21.75 pp |
| 2022 | 2022-12-31 | −33.64% | +91.99 pp |
| 2021 | 2021-12-31 | −125.63% | −32.58 pp |
| 2020 | 2020-12-31 | −93.05% | +21.50 pp |
| 2019 | 2019-12-28 | −114.54% | +23.53 pp |
| 2018 | 2018-12-29 | −138.07% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 12.50% | −10.74 pp |
| Q1 2026 | 2026-03-31 | 7.64% | −11.47 pp |
| Q4 2025 | 2025-12-31 | 13.23% | +6.13 pp |
| Q3 2025 | 2025-09-30 | 16.20% | +12.59 pp |
| Q2 2025 | 2025-06-30 | 23.24% | +12.29 pp |
| Q1 2025 | 2025-03-31 | 19.12% | +6.29 pp |
| Q4 2024 | 2024-12-31 | 7.11% | +3.90 pp |
| Q3 2024 | 2024-09-30 | 3.61% | +46.26 pp |
| Q2 2024 | 2024-06-30 | 10.94% | +12.67 pp |
| Q1 2024 | 2024-03-31 | 12.82% | +17.85 pp |
| Q4 2023 | 2023-12-31 | 3.21% | +23.90 pp |
| Q3 2023 | 2023-09-30 | −42.65% | −19.84 pp |
| Q2 2023 | 2023-06-30 | −1.73% | +45.76 pp |
| Q1 2023 | 2023-03-31 | −5.03% | +53.97 pp |
| Q4 2022 | 2022-12-31 | −20.70% | +96.47 pp |
| Q3 2022 | 2022-09-30 | −22.81% | +193.80 pp |
| Q2 2022 | 2022-06-30 | −47.49% | +66.37 pp |
| Q1 2022 | 2022-03-31 | −59.00% | +26.20 pp |
| Q4 2021 | 2021-12-31 | −117.17% | −45.42 pp |
| Q3 2021 | 2021-09-30 | −216.61% | −158.79 pp |
| Q2 2021 | 2021-06-30 | −113.86% | +86.53 pp |
| Q1 2021 | 2021-03-31 | −85.20% | +12.05 pp |
| Q4 2020 | 2020-12-31 | −71.75% | +62.77 pp |
| Q3 2020 | 2020-09-30 | −57.82% | +34.13 pp |
| Q2 2020 | 2020-06-30 | −200.38% | −76.41 pp |
| Q1 2020 | 2020-03-31 | −97.26% | +15.44 pp |
| Q4 2019 | 2019-12-28 | −134.52% | +29.34 pp |
| Q3 2019 | 2019-09-28 | −91.95% | −9.11 pp |
| Q2 2019 | 2019-06-29 | −123.97% | +33.99 pp |
| Q1 2019 · Mar 30 | 2019-03-30 | −112.70% | +60.77 pp |
| Q4 2018 | 2018-12-29 | −163.86% | — |
| Q3 2018 | 2018-09-29 | −82.84% | — |
| Q2 2018 | 2018-06-30 | −157.97% | — |
| Q1 2018 | 2018-03-31 | −173.48% | — |
Over the last five reported fiscal years, TransMedics Group's operating margin increased from −93.05% to 17.93%, a change of +110.98 percentage points. The latest reported quarter, Q2 2026, shows 12.50%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review TransMedics Group filings at SEC.gov ↗